参考文献

参考文献

［1］Ferlay J，Parkin DM，Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008［J］.Eur J Cancer，2010，46（4）：765-781.

［2］Torre LA，Bray F，Siegel RL，et al.Global cancer statistics，2012［J］.CA Cancer J Clin，2015，65（2）：87-108.

［3］Golse N，Adam R.Liver metastases from breast cancer：what role for surgery？indications and results［J］.Clin Breast Cancer，2017，17（4）：256-265.

［4］Obenauf AC，Massague J. Surviving at a distance：organ specific metastasis［J］.Trends Cancer，2015.1（1）：76-91.

［5］Guarneri V，Conte P.Metastatic breast cancer：therapeutic options according to molecular subtypes and prior adjuvant therapy［J］.Oncologist，2009，14（7）：645-656.

［6］Bishop AJ，Ensor J，Moulder SL，et al.Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy［J］.Cancer，2015，121（24）：4324-4332.

［7］Riihimäki M，Thomsen H，Sundquist K，et al.Clinical landscape of cancer metastases［J］.Cancer Med，2018，7（11）：5534-5542.

［8］Gradishar WJ，Anderson BO，Abraham J，et al.Breast cancer，version 3.2020，NCCN clinical practice guidelines in oncology［J］.J Natl Compr Canc Netw，2020，18（4）：452-478.

［9］Pispa J，Thesleff I.Mechanisms of ectodermal organogenesis［J］.Dev Biol，2003，262（2）：195-205.

［10］Kuei A，Saab S，Cho SK，et al.Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors［J］. World J Gastroenterol，2015，21（27）：8271-8283.

［11］Lobbezoo DJ，van Kampen RJ，Voogd AC，et al. Prognosis of metastatic breast cancer subtypes：the hormone receptor／HER-2-positive subtype is associated with the most favorable outcome［J］.Breast Cancer Res Treat，2013.141（3）：507-514.

［12］Coldman AJ，Phillips N. Breast cancer survival and prognosis by screening history［J］.British Journal of Cancer，2014，110（3）：556-559.

［13］Savci-Heijink CD，Halfwerk H，Hooijer GK，et al. Retrospective analysis of metastatic behaviour of breast cancer subtypes［J］.Breast Cancer Res Treat，2015，150（3）：547-557.(https://www.daowen.com)

［14］Cardoso F，Senkus E，Costa A，et al.4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer（ABC 4）dagger［J］.Ann Oncol，2018，29（8）：1634-1657.

［15］Abbott DE，Brouquet A，Mittendorf EA，et al.Resection of liver metastases from breast cancer：estrogen receptor status and response to chemotherapy before metastasectomy define outcome［J］. Surgery，2012，151（5）：710-716.

［16］Barral M，Auperin A，Hakime A，et al.Percutaneous thermal ablation of breast cancer metastases in oligometastatic patients［J］.Cardiovasc Intervent Radiol，2016，39（6）：885-893.

［17］Taşçi Y，Aksoy E，Taşkın HE，et al.A comparison of laparoscopic radiofrequency ablation versus systemic therapy alone in the treatment of breast cancer metastasis to the liver［J］.HPB（Oxford），2013，15（10）：789-793.

［18］Meloni MF，Andreano A，Laeseke PF，et al. Breast cancer liver metastases：US-guided percutaneous radiofrequency ablation—intermediate and long-term survival rates［J］.Radiology，2009，253（3）：861-869.

［19］Vogl TJ，Farshid P，Naguib NN，et al.Thermal ablation therapies in patients with breast cancer liver metastases：a review［J］.Eur Radiol，2013，23（3）：797-804.

［20］Pöpperl G，Helmberger T，Münzing W，et al. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors［J］.Cancer Biother Radiopharm，2005，20（2）：200-208.

［21］Cianni R，Pelle G，Notarianni E，et al.Radioembolisation with 90Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer［J］.Eur Radiol，2013，23（1）：182-189.

［22］Hoe A L，Royle G T，Taylor I.Breast liver metastases incidence，diagnosis and outcome［J］.J R Soc Med，1991，84（12）：714-716.

［23］Adam R，Chiche L，Aloia T，et al.Hepatic resection for noncolorectal nonendocrine liver metastases：analysis of 1，452 patients and development of a prognostic model［J］.Ann Surg，2006，244（4）：524-535.

［24］Takemura N，Saiura A.Role of surgical resection for non-colorectal non-neuroendocrine liver metastases［J］.World J Hepatol，2017，9（5）：242-251.

［25］Selzner M，Morse MA，Vredenburgh JJ，et al.Liver metastases from breast cancer：long-term survival after curative resection［J］.Surgery，2000，127（4）：383-389.

［26］Sakamoto Y，Yamamoto J，Yoshimoto M，et al.Hepatic resection for metastatic breast cancer：prognostic analysis of 34 patients［J］.World J Surg，2005，29（4）：524-527.